[HTML][HTML] Radiochemistry for positron emission tomography
Positron emission tomography (PET) constitutes a functional imaging technique that is
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …
harnessed to probe biological processes in vivo. PET imaging has been used to diagnose …
The oligometastatic spectrum in the era of improved detection and modern systemic therapy
Metastases remain the leading cause of cancer-related mortality. The oligometastasis
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
hypothesis postulates that a spectrum of metastatic spread exists and that some patients …
[HTML][HTML] Management of patients with advanced prostate cancer. Part I: intermediate-/high-risk and locally advanced disease, biochemical relapse, and side effects of …
Background Innovations in imaging and molecular characterisation and the evolution of new
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
therapies have improved outcomes in advanced prostate cancer. Nonetheless, we continue …
Appropriate use criteria for prostate-specific membrane antigen PET imaging
Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …
[HTML][HTML] Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
Background Nearly one-third of patients with prostate cancer (PCa) experience biochemical
recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant …
recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant …
In Situ Albumin-Hitchhiking NIR-II Probes for Accurate Detection of Micrometastases
Tumor metastasis remains the primary cause of treatment failure in cancer patients, and the
high-sensitivity preoperative and intraoperative detection of occult micrometastases …
high-sensitivity preoperative and intraoperative detection of occult micrometastases …
Diagnostic Performance and Safety of 18F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3 …
AB Jani, GC Ravizzini, BA Gartrell, BA Siegel… - The Journal of …, 2023 - auajournals.org
Purpose: SPOTLIGHT (NCT04186845) evaluated diagnostic performance and safety of
radiohybrid 18F-rhPSMA-7.3, a novel high-affinity positron emission tomography …
radiohybrid 18F-rhPSMA-7.3, a novel high-affinity positron emission tomography …
French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease
G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …
an update of the recommendations for the diagnosis and management of prostate cancer …
Best approaches and updates for prostate cancer biochemical recurrence
Biochemical recurrence develops in almost one-third of men with prostate cancer after
treatment with local therapy. There are numerous options for management, including …
treatment with local therapy. There are numerous options for management, including …
Effect of 18F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry …
U Metser, K Zukotynski, V Mak, D Langer, P MacCrostie… - Radiology, 2022 - pubs.rsna.org
Background The high positivity rate of prostate-specific membrane antigen (PSMA) PET in
the setting of biochemical failure (BCF), even when conventional imaging is negative, is …
the setting of biochemical failure (BCF), even when conventional imaging is negative, is …